收藏切换
Long-term survival simulation of immunotherapy: challenges and recommendations
收藏切换
Yitian LANG1, Xiaoyan LIU1, *, Bin WU2, *
World Clinical Drug | 2022, 43(10) : 1283 - 1291
Less
收藏切换
World Clinical Drug | 2022, 43(10): 1283-1291
• Topic •
Long-term survival simulation of immunotherapy: challenges and recommendations
Full
Yitian LANG1, Xiaoyan LIU1, *, Bin WU2, *
Affiliations
  • 1.Department of Pharmacy, Huangpu Branch, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China
  • 2.Clinical Research Centre, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
Published: 2022-10-10 doi: 10.13683/j.wph.2022.10.009
Outline
收藏切换
Objectives

Due to the unique mechanism of immunotherapy, the shape of its survival curve differs from that of conventional treatment. In order to better understand the causes of this type of survival curve and how to optimize the long-term simulation survival curves of immunotherapy, this study provides an introduction and an example demonstration to serve as a reference for relevant researchers.

Method

Taking the survival data of Checkmate-067 trial as an example, different survival models are used to extrapolate the survival data based on 0 to 27 months, and the results of extrapolated curve are compared with the actual survival curve of 28 to 60 months.

Results

In this example, the shape of overall survival curve is consistent with the conventional shape, and it is well fitted with different survival models, but the shape of progression free survival (PFS) curve with immunotherapy is significantly different from that with conventional therapy, and the fit is poor.

Conclusion

For the long-term survival simulation of immunotherapy, it is not recommended to select the model only considering the Akaike information criteria and Bayesian information criteria. Moreover, it is necessary to optimize the model based on the characteristics of immunotherapy, and making the corresponding fitting curve as far as possible for visual inspection. Also, the curve fitting requires special optimization or selection of a more flexible survival model when encountering the pseudo-progression or plateau.

survival simulation  /  pharmacoeconomics  /  immunotherapy  /  survival analysis
郎驿天, 刘晓琰, 吴斌. 免疫治疗长期生存模拟方法:挑战与建议. 世界临床药物, 2022 , 43 (10) : 1283 -1291 . DOI: 10.13683/j.wph.2022.10.009
Yitian LANG, Xiaoyan LIU, Bin WU. Long-term survival simulation of immunotherapy: challenges and recommendations[J]. World Clinical Drug, 2022 , 43 (10) : 1283 -1291 . DOI: 10.13683/j.wph.2022.10.009
Year 2022 volume 43 Issue 10
5
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.10.009
  • Receive Date:2022-08-12
  • Online Date:2026-11-18
  • Published:2022-10-10
Article Data
Affiliations
History
  • Received:2022-08-12
Affiliations
    1.Department of Pharmacy, Huangpu Branch, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200011, China
    2.Clinical Research Centre, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.10.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT